InsidersTradesSigma
Explore the complete record of transactions filed by Rothbaum Wayne P., Director. Director active across 1 companies, notably Iovance Biotherapeutics, INC.. Aggregated, 1 filings have been recorded. Total volume traded: €3.2m. The latest transaction was disclosed on 31 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Wayne P. Rothbaum is a Board Member at Iovance Biotherapeutics, Inc. He brings valuable expertise in biotechnology. His role involves overseeing the company's strategies and ensuring compliance with industry standards. Wayne contributes to strategic decision-making that influences innovation and growth at Iovance.